Govt. to give 12 Cr COVID vaccine doses in June 2021
7.94 crore doses were made available to the states in May 2021
7.94 crore doses were made available to the states in May 2021
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
The company plans to enter the EU markets in FY22
This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips
India sales grew 23.5% YoY with consolidation of Wockhardt products
A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month
Subscribe To Our Newsletter & Stay Updated